Innate Pharma (IPHA) Closes Sobi Deal. Can the New Funding Keep Drug Trials on Track?
Covered in this story
What has happened since
- Innate Pharma is down 12.2% since this was published, 12 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $IPHA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Innate Pharma →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.